#cirrhosis

A recent analysis of data from a roster of clinical trials yielded reassuring findings for this group of women who have hepatitis C.

Those for whom Mavyret did not work the first time had a high cure rate with this intensified retreatment regimen.

In a recent trial, 12 weeks of the drug combination worked well regardless of whether individuals had drug-resistant virus.

Treating hepatitis C among those with cirrhosis reduces hospitalizations.

Use of drugs like Nexium or Prilosec is tied to progression to cirrhosis, decompensated cirrhosis and liver cancer in this population.

However, in a small subset of those with advanced fibrosis or cirrhosis, liver damage remains the same or worsens post-cure.

AZT and ddI were the main drugs associated with liver damage in a new study.

Can’t get enough of the Olympics? Read Karen Hoyt’s heartwarming account of her participation in the World Transplant Games.

A recent study in mice found that a high dose of green tea extract had a beneficial effect on a new sign of liver cancer progression.